BCBrennan Callow

Brennan Callow

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Brennan Callow has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Acetyltransferase MOF Regulates Macrophage Inflammation in Abdominal Aortic Aneurysms

    by Xiaobing He, Nicholas Juriga, Sama Salih, Brennan Callow, Dominique Pierre-Louis, Amrita Joshi, Rachael Bogle, Lam C. Tsoi, Andrea Tara Obi, Johann E. Gudjonsson, et al.

    BACKGROUND: Abdominal aortic aneurysms (AAAs) are a life-threatening cardiovascular disease for which there is a lack of therapy preventing aortic rupture. During AAA formation, pathological vascular remodeling is driven by an imbalance of proinflammatory and anti-inflammatory macrophage responses, and mechanisms regulating macrophage-mediated inflammation remain undefined. Recent evidence suggests that males absent on the first (MOF), a histone acetyltransferase, can play a critical role in establishing macrophage phenotype and modulating innate immune response. METHODS: Single-cell RNA sequencing analysis of human AAAs and control tissues was performed to analyze MOF expression in aortic monocyte/macrophages and the inflammatory immune response. Mice underwent 2 murine AAA models: either Ang II (angiotensin II) or topical porcine pancreatic elastase. To investigate the role of MOF in AAA development, targeted inhibition was performed with MG-149 administration or in mice genetically deficient in macrophage-specific MOF ( Mof f/f Lyz2 Cre+ ). Finally, flow cytometry and chromatin immunoprecipitation were conducted to analyze macrophage phenotype and levels of histone (H) lysine (K) acetylation (H4K16ac) in human and murine AAA macrophages. RESULTS: Using single-cell RNA sequencing of human AAA tissues and multiple murine AAA models, we identified that MOF is increased in aortic monocyte/macrophages associated with upregulation of inflammatory transcriptional programs. Mechanistically, TNF-α (tumor necrosis factor alpha) signaling promotes the induction of MOF, which in turn induces NF-κB (nuclear factor kappa-light-chain-enhancer of activated B)–mediated inflammatory gene transcription by increasing the activating H4K16ac mark on gene promoters in infiltrating aortic macrophages. In vivo targeted inhibition of the MOF pathway, with myeloid-specific genetic depletion ( Mof f/f Lyz2 Cre+ ) or pharmacological inhibition in the elastase- and angiotensin II–induced AAA model, preserved macrophage function, decreased elastin fragmentation, attenuated aortic inflammation, and markedly reduced AAA development. CONCLUSIONS: Our study provides important evidence that MOF regulates macrophage phenotypic function and inflammation during human and murine AAA development. Targeting the MOF pathway affords the opportunity to prevent pathological macrophage infiltration within the aortic wall and potentially limit AAA development.

  • MLL1 Regulates T-Cell Phenotype via Notch Signaling During Abdominal Aortic Aneurysm Development

    by Xiaobing He, Nicholas Juriga, Brennan Callow, Sama Salih, Amrita Joshi, Rachael Bogle, Lam C. Tsoi, Andrea T. Obi, Johann E. Gudjonsson, Katherine A. Gallagher, et al.

    BACKGROUND: Abdominal aortic aneurysms (AAA) are characterized by progressive pathological vascular remodeling and a dysregulated immune microenvironment marked by an imbalance between anti-inflammatory regulatory T cells and proinflammatory T helper 17 (Th17) cells within the aortic wall. The molecular mechanisms governing CD4 + (cluster of differentiation) T-cell differentiation during AAA development remain incompletely defined. MLL1 (mixed lineage leukemia 1), a histone methyltransferase, has recently been shown to modulate T-cell lineage commitment through epigenetic regulation of transcriptional programs in multiple inflammatory diseases. We, therefore, sought to determine whether MLL1 promotes Th17 polarization during AAA development and to identify signaling pathways through which MLL1 regulates CD4 + T-cell infiltration and phenotype. METHODS: Single-cell RNA-sequencing was performed on human AAA and nonaneurysmal aortic tissues. Two murine AAA models were utilized: AngII (angiotensin II) infusion with adeno-associated virus–mediated PCSK9 (proprotein convertase subtilisin/kexin type 9) gain-of-function expression and topical porcine pancreatic elastase application in C57BL/6J mice. Mice with CD4 + T-cell–specific deletion of Notch signaling ( DNMAML fl/fl CD4 cre+ ), Notch1 ( Notch1 fl/fl CD4 cre+ ), or MLL1 ( Mll1 fl/fl CD4 cre+ ) were subjected to AngII infusion, and aneurysm diameter was quantified. CD4 + T cells were isolated by magnetic-activated cell sorting for gene expression analysis and flow cytometric phenotyping. Chromatin immunoprecipitation assessed H3K4 trimethylation enrichment at target gene promoters. RESULTS: Single-cell sequencing of human AAA tissue demonstrated marked upregulation of MLL1 and Notch1 signaling in CD4 + T cells compared with controls. Both human AAA and murine AngII-induced AAA CD4 + T cells exhibited a predominant Th17 phenotype with increased MLL1 expression. Chromatin immunoprecipitation analysis revealed enhanced MLL1-mediated H3K4 trimethylation enrichment at the Notch1 promoter. Mice deficient in CD4 + Th-cell Notch signaling ( DNMAML fl/fl CD4 cre+ or Notch1 fl/fl CD4 cre+ ) or MLL1 ( Mll1 fl/fl CD4 cre+ ) displayed a significant reduction in aneurysm formation, decreased Th17 activity, and increased regulatory T cell expression. CONCLUSIONS: MLL1 epigenetically regulates Notch1 signaling to drive pathogenic Th17 polarization during AAA development. Targeting the MLL1 axis may represent a novel therapeutic strategy to limit aneurysmal progression.

  • Open Access

    Association Between Creation of an Endovascular Aortic Aneurysm Surveillance Program and 1-Year Follow-Up and Mortality in the State of Michigan, United States

    by Frank M. Davis, Jeremy Albright, Brennan Callow, Loay Kabbani, Hue Thai, Tamer Boules, Nicolas J. Mouawad, Nicholas Harold Osborne

    BACKGROUND: National guidelines recommend long-term surveillance after endovascular abdominal aortic aneurysm repair (EVAR) to monitor for device failure; however, investigations have demonstrated that EVAR surveillance can vary greatly. Recently, the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) implemented a statewide surveillance program, linked with financial reimbursement, designed to improve EVAR postoperative surveillance. The purpose of this study was to evaluate the impact of this statewide program on EVAR surveillance and long-term mortality. METHODS: The BMC2, a prospective, multicenter registry consisting of 36 hospitals, was queried for patients who underwent EVAR between 2017 and 2023 in the state of Michigan, United States. Patient, hospital, and operative factors were analyzed based on the presence or absence of EVAR surveillance imaging determined by computed tomography imaging. Covariate-adjusted Bayesian logistic models were used to identify the impact of surveillance imaging on reinterventions and 1-year mortality. The primary outcome was completion of EVAR surveillance and the longitudinal change in the percent of EVARs that obtained surveillance imaging following implementation of the EVAR surveillance program. RESULTS: A total of 5583 patients with a mean age of 72.6 years and 81% male underwent EVAR between 2017 and 2023. During the implementation of the EVAR surveillance program, there was a steady increase in the percentage of 1-year EVAR surveillance imaging performed (27.8% in 2017 to 77.9% in 2023). On mixed logistic modeling, patients who received EVAR surveillance displayed a decreased odds ratio of 1-year mortality (0.39 [0.23–0.65]) compared with those who did not receive EVAR surveillance. CONCLUSIONS: Incomplete imaging surveillance following EVAR remains high and predisposes patients to worse outcomes. Utilization of a surveillance program with an associated financial incentive, is a viable strategy that can have a significant impact on increasing EVAR surveillance and decreasing 1-year mortality after EVAR.